Added to YB: 2026-01-15
Pitch date: 2026-01-13
TECN.SW [bullish]
Tecan Group AG
-2.09%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
Market Cap
CHF 2.0B
Pitch Price
CHF 157.90
Price Target
N/A
Dividend
1.87%
EV/EBITDA
16.72
P/E
32.38
EV/Sales
2.16
Sector
Life Sciences Tools and Services
Category
turnaround
Tecan Group (TECN Switzerland): early signs of life, with orders pointing to a gradual recovery
TECN.SW (update): 2025 sales CHF 882.5M, flat YOY but H2 orders up 9% in local currencies with book-to-bill >1 signaling gradual recovery. Life sciences tools cyclical headwinds stabilizing, not structural issues. Stock pricing prolonged subdued growth despite solid installed base across diagnostics/biopharma. Valuation gap vs improving order trends.
Read full article (2 min)